Moving towards non-invasive assessments of prognosis in osteosarcoma.
Kolb
E Anders
EA
Division of Hematology and Oncology, A.I. duPont Hospital for Children, Wilmington, Delaware 19803, USA. eakolb@nemours.org
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D001859:Bone Neoplasms / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007089:Image Enhancement; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging / Q000379:methods*; D012516:Osteosarcoma / Q000378:metabolism / Q000473:pathology*; D011379:Prognosis; D042461:Vascular Endothelial Growth Factor A / Q000032:analysis / Q000378:metabolism*
D014408:Biomarkers, Tumor; D042461:Vascular Endothelial Growth Factor A